Yujue Wang
David Geffen School of Medicine at UCLA
1 paper found
Refreshing results…
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
UploadMissing publications? Search for publications with a matching author name.